Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Ophthalmic Equipment

PUBLISHER: Azoth Analytics | PRODUCT CODE: 1550023

Cover Image

PUBLISHER: Azoth Analytics | PRODUCT CODE: 1550023

Global Ophthalmic Disease Therapeutics Market : Analysis By Indication, By Therapies, By Distribution Channel, By Region, By Country: Market Insights and Forecast

PUBLISHED:
PAGES: 253 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 2450
PDF (Enterprise License)
USD 2950

Add to Cart

Description

Table of Contents

List of Tables

Executive Summary

Azoth Analytics has released a research report titled "Global Ophthalmic Disease Therapeutics Market (2024 Edition)" which provides a Age-related macular degeneration analysis of the Global Ophthalmic Disease Therapeutics industry in terms of market segmentation By Indication (Age-related macular degeneration, Diabetic macular edema), By Therapies (Anti VEGF, Antibody - anti-IGF-1R, Eye drops, Other Therapies) By Distribution Channel (Hospital Pharmacies, Retail & Online Pharmacies) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030.

The report analyses the Ophthalmic Disease Therapeutics Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). The Global Ophthalmic Disease Therapeutics market showcased growth at a CAGR of 3.81% during 2020-2023. The market was valued at USD 21.92 Billion in 2023 which is expected to reach USD 31.67 Billion in 2030.

Eye diseases are becoming more prevalent, particularly in aging populations. According to the World Health Organization (WHO), over 2.2 billion people globally are affected by vision impairment or blindness, with at least 1 billion cases being preventable or treatable.

The global ophthalmic disease therapeutics market is projected to exhibit robust growth during the forecast period. Factors such as the introduction of innovative treatment options, rising disposable incomes, and expanding healthcare infrastructure are anticipated to propel market expansion.

The rising incidence of lifestyle-related eye diseases, such as diabetic retinopathy and computer vision syndrome, is contributing to market expansion. Advancements in ophthalmic research and development have led to the development of novel therapies, thereby creating new growth opportunities. Additionally, increasing healthcare expenditure and rising disposable incomes are enabling greater access to ophthalmic care, further stimulating market growth.

Moreover, public health initiatives and increased awareness about eye diseases are improving early diagnosis and treatment, particularly in developed regions.

Scope of the Report:

  • The report analyses the Ophthalmic Disease Therapeutics Market by Value (USD Billion).
  • The report analyses the Ophthalmic Disease Therapeutics Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India).
  • The report presents the analysis of Ophthalmic Disease Therapeutics Market for the historical period of 2020-2023, the estimated year 2024 and the forecast period of 2025-2030.
  • The report analyses the Ophthalmic Disease Therapeutics Market By Indication (Age-related macular degeneration, Diabetic macular edema, Other retinal disorders)
  • The report analyses the Ophthalmic Disease Therapeutics Market By Therapies (Anti VEGF, Antibody - anti-IGF-1R, and Eye drops, and Other Therapies).
  • The report analyses the Ophthalmic Disease Therapeutics Market By Distribution Channel (Hospital Pharmacies, Retail & Online Pharmacies).
  • The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, By Indication, By Therapies and By Distribution Channel.
  • Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analyzed in the report include Horizon Therapeutics, Viridian Therapeutics, Viatris, Sanofi Novartis, Bayer AG, Teva Pharmaceuticals, F. Hoffmann-La Roche AG, AbbVie, and GSK plc.
Show more

Table of Contents

1. Market Background

  • 1.1 Scope and Product Outlook
  • 1.2 Executive Summary
  • 1.3 Research Methodology

2. Analyst Recommendations

  • 2.1 Focus on Rare Eye Diseases
  • 2.2 Growing Role of Artificial Intelligence in Diagnosis and Treatment

3. Global Ophthalmic Disease Therapeutics Market: Historic and Forecast

  • 3.1 Impact Analysis of Macro Economic Factors on Ophthalmic Disease Therapeutics Market
  • 3.2 Age wise prevalence of Glaucoma
  • 3.3 Global Prevalence of Ophthalmic Diseases, 2021
  • 3.4 Prevalence of Age-related macular degeneration, 2021
  • 3.5 Global Ophthalmic Disease Therapeutics Market: Dashboard
  • 3.6 Global Ophthalmic Disease Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
  • 3.7 Global Ophthalmic Disease Therapeutics Market: Market Value Assessment
  • 3.8 Assessment Degree of Impact of COVID-19 on Global Ophthalmic Disease Therapeutics Market
  • 3.9 Global Ophthalmic Disease Therapeutics Market Segmentation: By Indication
    • 3.9.1 Global Ophthalmic Disease Therapeutics Market, By Indication Overview
    • 3.9.2 Global Ophthalmic Disease Therapeutics Market Attractiveness Index, By Indication
    • 3.9.3 Global Ophthalmic Disease Therapeutics Market Size, By Age-related macular degeneration , By Value, 2020H-2030F (USD Billion & CAGR)
    • 3.9.4 Global Ophthalmic Disease Therapeutics Market Size, By Diabetic macular edema, By Value, 2020H-2030F (USD Billion & CAGR)
    • 3.9.5 Global Ophthalmic Disease Therapeutics Market Size, By Other retinal disorders , By Value, 2020H-2030F (USD Billion & CAGR)
  • 3.10 Global Ophthalmic Disease Therapeutics Market Segmentation: By Therapies
    • 3.10.1 Global Ophthalmic Disease Therapeutics Market, By Therapies Overview
    • 3.10.2 Global Ophthalmic Disease Therapeutics Market Attractiveness Index, By Therapies
    • 3.10.3 Global Ophthalmic Disease Therapeutics Market Size, By Anti VEGF, By Value, 2020H-2030F (USD Billion & CAGR)
    • 3.10.4 Global Ophthalmic Disease Therapeutics Market Size, By Antibody - anti-IGF-1R, By Value, 2020H-2030F (USD Billion & CAGR)
    • 3.10.5 Global Ophthalmic Disease Therapeutics Market Size, By Eye drops, By Value, 2020H-2030F (USD Billion & CAGR)
    • 3.10.6 Global Ophthalmic Disease Therapeutics Market Size, By Other Therapies, By Value, 2020H-2030F (USD Billion & CAGR)
  • 3.11 Global Ophthalmic Disease Therapeutics Market Segmentation: By Distribution Channel
    • 3.11.1 Global Ophthalmic Disease Therapeutics Market, By Distribution Channel Overview
    • 3.11.2 Global Ophthalmic Disease Therapeutics Market Attractiveness Index, By Distribution Channel
    • 3.11.3 Global Ophthalmic Disease Therapeutics Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
    • 3.11.4 Global Ophthalmic Disease Therapeutics Market Size, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)

4. Ophthalmic Disease Therapeutics Market, Region Analysis

  • 4.1 Regional Coverage of the Study
  • 4.2 Regional Snapshot

5. Americas Ophthalmic Disease Therapeutics Market: Historic and Forecast

  • 5.1 Americas Ophthalmic Disease Therapeutics Market: Snapshot
  • 5.2 Americas Ophthalmic Disease Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
  • 5.3 Americas Ophthalmic Disease Therapeutics Market: Key Factors
  • 5.4 Americas Ophthalmic Disease Therapeutics Market: Segment Analysis
  • 5.5 Americas Ophthalmic Disease Therapeutics Market Segmentation: By Indication
    • 5.5.1 Americas Ophthalmic Disease Therapeutics Market, By Indication Overview
    • 5.5.2 Americas Ophthalmic Disease Therapeutics Market Size, By Age-related macular degeneration , By Value, 2020H-2030F (USD Billion & CAGR)
    • 5.5.3 Americas Ophthalmic Disease Therapeutics Market Size, By Diabetic macular edema, By Value, 2020H-2030F (USD Billion & CAGR)
    • 5.5.4 Americas Ophthalmic Disease Therapeutics Market Size, By Other retinal disorders, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.6 Americas Ophthalmic Disease Therapeutics Market Segmentation: Therapies
    • 5.6.1 Americas Ophthalmic Disease Therapeutics Market, By Therapies Overview
    • 5.6.2 Americas Ophthalmic Disease Therapeutics Market Size, By Anti VEGF, By Value, 2020H-2030F (USD Billion & CAGR)
    • 5.6.3 Americas Ophthalmic Disease Therapeutics Market Size, By Antibody - anti-IGF-1R, By Value, 2020H-2030F (USD Billion & CAGR)
    • 5.6.4 Americas Ophthalmic Disease Therapeutics Market Size, By Eye drops, By Value, 2020H-2030F (USD Billion & CAGR)
    • 5.6.5 Americas Ophthalmic Disease Therapeutics Market Size, By Other Therapies, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.7 Americas Ophthalmic Disease Therapeutics Market Segmentation: By Distribution Channel
    • 5.7.1 Americas Ophthalmic Disease Therapeutics Market, By Distribution Channel Overview
    • 5.7.2 Americas Ophthalmic Disease Therapeutics Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
    • 5.7.3 Americas Ophthalmic Disease Therapeutics Market Size, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.8 Americas Ophthalmic Disease Therapeutics Market Segmentation: By Country
    • 5.8.1 Americas Ophthalmic Disease Therapeutics Market, by Country Overview
    • 5.8.2 United States Ophthalmic Disease Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 5.8.2.1 United States Ophthalmic Disease Therapeutics Market, By Indication
      • 5.8.2.2 United States Ophthalmic Disease Therapeutics Market, By Therapies
      • 5.8.2.3 United States Ophthalmic Disease Therapeutics Market, By Distribution Channel
    • 5.8.3 Canada Ophthalmic Disease Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 5.8.3.1 Canada Ophthalmic Disease Therapeutics Market, By Indication
      • 5.8.3.2 Canada Ophthalmic Disease Therapeutics Market, By Therapies
      • 5.8.3.3 Canada Ophthalmic Disease Therapeutics Market, By Distribution Channel
    • 5.8.4 Rest of Americas Ophthalmic Disease Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 5.8.4.1 Rest of Americas Ophthalmic Disease Therapeutics Market, By Indication
      • 5.8.4.2 Rest of Americas Ophthalmic Disease Therapeutics Market, By Therapies
      • 5.8.4.3 Rest of Americas Ophthalmic Disease Therapeutics Market, By Distribution Channel

6. Europe Ophthalmic Disease Therapeutics Market: Historic and Forecast

  • 6.1 Europe Ophthalmic Disease Therapeutics Market: Snapshot
  • 6.2 Europe Ophthalmic Disease Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
  • 6.3 Europe Ophthalmic Disease Therapeutics Market: Key Factors
  • 6.4 Europe Ophthalmic Disease Therapeutics Market: Segment Analysis
  • 6.5 Europe Ophthalmic Disease Therapeutics Market Segmentation: By Indication
    • 6.5.1 Europe Ophthalmic Disease Therapeutics Market, By Indication Overview
    • 6.5.2 Europe Ophthalmic Disease Therapeutics Market Size, By Age-related macular degeneration , By Value, 2020H-2030F (USD Billion & CAGR)
    • 6.5.3 Europe Ophthalmic Disease Therapeutics Market Size, By Diabetic macular edema, By Value, 2020H-2030F (USD Billion & CAGR)
    • 6.5.4 Europe Ophthalmic Disease Therapeutics Market Size, By Other retinal disorders, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.6 Europe Ophthalmic Disease Therapeutics Market Segmentation: By Therapies
    • 6.6.1 Europe Ophthalmic Disease Therapeutics Market, By Therapies Overview
    • 6.6.2 Europe Ophthalmic Disease Therapeutics Market Size, By Anti VEGF, By Value, 2020H-2030F (USD Billion & CAGR)
    • 6.6.3 Europe Ophthalmic Disease Therapeutics Market Size, By Antibody - anti-IGF-1R, By Value, 2020H-2030F (USD Billion & CAGR)
    • 6.6.3 Europe Ophthalmic Disease Therapeutics Market Size, By Eye drops, By Value, 2020H-2030F (USD Billion & CAGR)
    • 6.6.4 Europe Ophthalmic Disease Therapeutics Market Size, By Other Therapies, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.7 Europe Ophthalmic Disease Therapeutics Market Segmentation: By Distribution Channel
    • 6.7.1 Europe Ophthalmic Disease Therapeutics Market, By Distribution Channel Overview
    • 6.7.2 Europe Ophthalmic Disease Therapeutics Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
    • 6.7.3 Europe Ophthalmic Disease Therapeutics Market Size, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.8 Europe Ophthalmic Disease Therapeutics Market Segmentation: By Country
    • 6.8.1 Europe Ophthalmic Disease Therapeutics Market, by Country Overview
    • 6.8.2 Germany Ophthalmic Disease Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.8.2.1 Germany Ophthalmic Disease Therapeutics Market, By Indication
      • 6.8.2.2 Germany Ophthalmic Disease Therapeutics Market, By Therapies
      • 6.8.2.3 Germany Ophthalmic Disease Therapeutics Market, By Distribution Channel
    • 6.8.3 United Kingdom Ophthalmic Disease Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.8.3.1 United Kingdom Ophthalmic Disease Therapeutics Market, By Indication
      • 6.8.3.2 United Kingdom Ophthalmic Disease Therapeutics Market, By Therapies
      • 6.8.3.3 United Kingdom Ophthalmic Disease Therapeutics Market, By Distribution Channel
    • 6.8.4 France Ophthalmic Disease Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.8.4.1 France Ophthalmic Disease Therapeutics Market, By Indication
      • 6.8.4.2 France Ophthalmic Disease Therapeutics Market, By Therapies
      • 6.8.4.3 France Ophthalmic Disease Therapeutics Market, By Distribution Channel
    • 6.8.5 Italy Ophthalmic Disease Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.8.5.1 Italy Ophthalmic Disease Therapeutics Market, By Indication
      • 6.8.5.2 Italy Ophthalmic Disease Therapeutics Market, By Therapies
      • 6.8.5.3 Italy Ophthalmic Disease Therapeutics Market, By Distribution Channel
    • 6.8.6 Spain Ophthalmic Disease Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.8.6.1 Spain Ophthalmic Disease Therapeutics Market, By Indication
      • 6.8.6.2 Spain Ophthalmic Disease Therapeutics Market, By Therapies
      • 6.8.6.3 Spain Ophthalmic Disease Therapeutics Market, By Distribution Channel
    • 6.8.7 Rest of Europe Ophthalmic Disease Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.8.7.1 Rest of Europe Ophthalmic Disease Therapeutics Market, By Indication
      • 6.8.7.2 Rest of Europe Ophthalmic Disease Therapeutics Market, By Therapies
      • 6.8.7.3 Rest of Europe Ophthalmic Disease Therapeutics Market, By Distribution Channel

7. Asia Pacific Ophthalmic Disease Therapeutics Market: Historic and Forecast

  • 7.1 Asia Pacific Ophthalmic Disease Therapeutics Market: Snapshot
  • 7.2 Asia Pacific Ophthalmic Disease Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
  • 7.3 Asia Pacific Ophthalmic Disease Therapeutics Market: Key Factors
  • 7.4 Asia Pacific Ophthalmic Disease Therapeutics Market: Segment Analysis
  • 7.5 Asia Pacific Ophthalmic Disease Therapeutics Market Segmentation: By Indication
    • 7.5.1 Asia Pacific Ophthalmic Disease Therapeutics Market, By Indication Overview
    • 7.5.2 Asia Pacific Ophthalmic Disease Therapeutics Market Size, By Age-related macular degeneration , By Value, 2020H-2030F (USD Billion & CAGR)
    • 7.5.3 Asia Pacific Ophthalmic Disease Therapeutics Market Size, By Diabetic macular edema, By Value, 2020H-2030F (USD Billion & CAGR)
    • 7.5.4 Asia Pacific Ophthalmic Disease Therapeutics Market Size, By Other retinal disorders, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.6 Asia Pacific Ophthalmic Disease Therapeutics Market Segmentation: By Therapies
    • 7.6.1 Asia Pacific Ophthalmic Disease Therapeutics Market, By Therapies Overview
    • 7.6.2 Asia Pacific Ophthalmic Disease Therapeutics Market Size, By Anti VEGF, By Value, 2020H-2030F (USD Billion & CAGR)
    • 7.6.3 Asia Pacific Ophthalmic Disease Therapeutics Market Size, By Antibody - anti-IGF-1R, By Value, 2020H-2030F (USD Billion & CAGR)
    • 7.6.3 Asia Pacific Ophthalmic Disease Therapeutics Market Size, By Eye drops, By Value, 2020H-2030F (USD Billion & CAGR)
    • 7.6.4 Asia Pacific Ophthalmic Disease Therapeutics Market Size, By Other Therapies, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.7 Asia Pacific Ophthalmic Disease Therapeutics Market Segmentation: By Distribution Channel
    • 7.7.1 Asia Pacific Ophthalmic Disease Therapeutics Market, By Distribution Channel Overview
    • 7.7.2 Asia Pacific Ophthalmic Disease Therapeutics Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
    • 7.7.3 Asia Pacific Ophthalmic Disease Therapeutics Market Size, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.8 Asia Pacific Ophthalmic Disease Therapeutics Market Segmentation: By Country
    • 7.8.1 Asia Pacific Ophthalmic Disease Therapeutics Market, by Country Overview
    • 7.8.2 China Ophthalmic Disease Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 7.8.2.1 China Ophthalmic Disease Therapeutics Market, By Indication
      • 7.8.2.2 China Ophthalmic Disease Therapeutics Market, By Therapies
      • 7.8.2.3 China Ophthalmic Disease Therapeutics Market, By Distribution Channel
    • 7.8.3 Japan Ophthalmic Disease Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 7.8.3.1 Japan Ophthalmic Disease Therapeutics Market, By Indication
      • 7.8.3.2 Japan Ophthalmic Disease Therapeutics Market, By Therapies
      • 7.8.3.3 Japan Ophthalmic Disease Therapeutics Market, By Distribution Channel
    • 7.8.4 India Ophthalmic Disease Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 7.8.4.1 India Ophthalmic Disease Therapeutics Market, By Indication
      • 7.8.4.2 India Ophthalmic Disease Therapeutics Market, By Therapies
      • 7.8.4.3 India Ophthalmic Disease Therapeutics Market, By Distribution Channel
    • 7.8.5 Rest of Asia Pacific Ophthalmic Disease Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 7.8.5.1 Rest of Asia Pacific Ophthalmic Disease Therapeutics Market, By Indication
      • 7.8.5.2 Rest of Asia Pacific Ophthalmic Disease Therapeutics Market, By Therapies
      • 7.8.5.3 Rest of Asia Pacific Ophthalmic Disease Therapeutics Market, By Distribution Channel

8. Middle East and Africa Ophthalmic Disease Therapeutics Market: Historic and Forecast

  • 8.1 Middle East and Africa Ophthalmic Disease Therapeutics Market: Snapshot
  • 8.2 Middle East and Africa Ophthalmic Disease Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
  • 8.3 Middle East and Africa Ophthalmic Disease Therapeutics Market: Key Factors
  • 8.4 Middle East and Africa Ophthalmic Disease Therapeutics Market: Segment Analysis
  • 8.5 Middle East and Africa Ophthalmic Disease Therapeutics Market Segmentation: By Indication
    • 8.5.1 Middle East and Africa Ophthalmic Disease Therapeutics Market, By Indication Overview
    • 8.5.2 Middle East and Africa Ophthalmic Disease Therapeutics Market Size, By Age-related macular degeneration , By Value, 2020H-2030F (USD Billion & CAGR)
    • 8.5.3 Middle East and Africa Ophthalmic Disease Therapeutics Market Size, By Diabetic macular edema, By Value, 2020H-2030F (USD Billion & CAGR)
    • 8.5.4 Middle East and Africa Ophthalmic Disease Therapeutics Market Size, By Other retinal disorders, By Value, 2020H-2030F (USD Billion & CAGR)
  • 8.6 Middle East and Africa Ophthalmic Disease Therapeutics Market Segmentation: By Therapies
    • 8.6.1 Middle East and Africa Ophthalmic Disease Therapeutics Market, By Therapies Overview
    • 8.6.2 Middle East and Africa Ophthalmic Disease Therapeutics Market Size, By Anti VEGF, By Value, 2020H-2030F (USD Billion & CAGR)
    • 8.6.3 Middle East and Africa Ophthalmic Disease Therapeutics Market Size, By Antibody - anti-IGF-1R, By Value, 2020H-2030F (USD Billion & CAGR)
    • 8.6.3 Middle East and Africa Ophthalmic Disease Therapeutics Market Size, By Eye drops, By Value, 2020H-2030F (USD Billion & CAGR)
    • 8.6.4 Middle East and Africa Ophthalmic Disease Therapeutics Market Size, By Other Therapies, By Value, 2020H-2030F (USD Billion & CAGR)
  • 8.7 Middle East and Africa Ophthalmic Disease Therapeutics Market Segmentation: By Distribution Channel
    • 8.7.1 Middle East and Africa Ophthalmic Disease Therapeutics Market, By Distribution Channel Overview
    • 8.7.2 Middle East and Africa Ophthalmic Disease Therapeutics Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
    • 8.7.3 Middle East and Africa Ophthalmic Disease Therapeutics Market Size, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)

9. Market Dynamics

  • 9.1 Impact assessment of Market Dynamics on Ophthalmic Disease Therapeutics Market
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Trends

10. Industry Ecosystem Analysis

  • 10.1 Porter Analysis

11. Competitive Positioning

  • 11.1 Companies' Product Positioning
  • 11.2 Market Position Matrix
  • 11.3 Market Share Analysis of Ophthalmic Disease Therapeutics Market
  • 11.4 Company Profiles
    • 11.4.1 Horizon Therapeutics
    • 11.4.2 Viridian Therapeutics
    • 11.4.3 Viatris
    • 11.4.4 Sanofi
    • 11.4.5 Novartis AG
    • 11.4.6 Bayer AG
    • 11.4.7 Teva Pharmaceuticals
    • 11.4.8 F. Hoffmann-La Roche AG
    • 11.4.9 AbbVie
    • 11.4.10 GSK plc

12. About Us & Disclaimer

Show more

List of Figures

  • Figure 1: Age wise prevalence of Glaucoma, 2023
  • Figure 2: Global Prevalence of Ophthalmic Diseases, 2021
  • Figure 3: Prevalence of Age-related macular degeneration, 2021
  • Figure 4: Global Ophthalmic Disease Therapeutics Market Size, By Value, 2020-2023 (USD Billion)
  • Figure 5: Global Ophthalmic Disease Therapeutics Market Size, By Value, 2024-2030 (USD Billion)
  • Figure 6: Global Ophthalmic Disease Therapeutics Market Share, By Distribution Channel, 2023 (%)
  • Figure 7: Market Attractiveness Analysis of Ophthalmic Disease Therapeutics Market, By Indication (2025-2030)
  • Figure 8: Global Ophthalmic Disease Therapeutics Market Size, By Age-related macular degeneration , By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 9: Global Ophthalmic Disease Therapeutics Market Absolute Opportunity, By Age-related macular degeneration , 2020-2030 (USD Billion)
  • Figure 10: Global Ophthalmic Disease Therapeutics Market Size, By Diabetic macular edema, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 11: Global Ophthalmic Disease Therapeutics Market Absolute Opportunity, By Diabetic macular edema, 2020-2030 (USD Billion)
  • Figure 12: Global Ophthalmic Disease Therapeutics Market Size, By Other retinal disorders, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 13: Global Ophthalmic Disease Therapeutics Market Absolute Opportunity, By Other retinal disorders, 2020-2030 (USD Billion)
  • Figure 14: Market Attractiveness Analysis of Ophthalmic Disease Therapeutics Market, By Therapies (2025-2030)
  • Figure 15: Global Ophthalmic Disease Therapeutics Market Size, By Anti VEGF, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 16: Global Ophthalmic Disease Therapeutics Market Absolute Opportunity, By Anti VEGF, 2020-2030 (USD Billion)
  • Figure 17: Global Ophthalmic Disease Therapeutics Market Size, By Antibody - anti-IGF-1R, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 18: Global Ophthalmic Disease Therapeutics Market Absolute Opportunity, By Antibody - anti-IGF-1R, 2020-2030 (USD Billion)
  • Figure 19: Global Ophthalmic Disease Therapeutics Market Size, By Eye drops, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 20: Global Ophthalmic Disease Therapeutics Market Absolute Opportunity, By Eye drops, 2020-2030 (USD Billion)
  • Figure 21: Global Ophthalmic Disease Therapeutics Market Size, By Other Therapies, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 22: Global Ophthalmic Disease Therapeutics Market Absolute Opportunity, By Other Therapies, 2020-2030 (USD Billion)
  • Figure 23: Market Attractiveness Analysis of Ophthalmic Disease Therapeutics Market, By Distribution Channel (2025-2030)
  • Figure 24: Global Ophthalmic Disease Therapeutics Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 25: Global Ophthalmic Disease Therapeutics Market Absolute Opportunity, By Hospital Pharmacies, 2020-2030 (USD Billion)
  • Figure 26: Global Ophthalmic Disease Therapeutics Market Size, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 27: Global Ophthalmic Disease Therapeutics Market Absolute Opportunity, By Retail & Online Pharmacies, 2020-2030 (USD Billion)
  • Figure 28: Americas Ophthalmic Disease Therapeutics Market Size, By Value, 2020H-2030F (USD Billion)
  • Figure 29: Americas Ophthalmic Disease Therapeutics Market Share, By Distribution Channel, 2023 (%)
  • Figure 30: Americas Ophthalmic Disease Therapeutics Market, By Age-related macular degeneration , By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 31: Americas Ophthalmic Disease Therapeutics Market, By Diabetic macular edema, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 32: Americas Ophthalmic Disease Therapeutics Market, By Other retinal disorders, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 33: Americas Ophthalmic Disease Therapeutics Market, By Anti VEGF, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 34: Americas Ophthalmic Disease Therapeutics Market, By Antibody - anti-IGF-1R, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 35: Americas Ophthalmic Disease Therapeutics Market, By Eye drops, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 36: Americas Ophthalmic Disease Therapeutics Market, By Other Therapies, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 37: Americas Ophthalmic Disease Therapeutics Market, By Hospital Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 38: Americas Ophthalmic Disease Therapeutics Market, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 39: United States Ophthalmic Disease Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 40: United States Ophthalmic Disease Therapeutics Market Value, By Therapies, 2023 (USD Billion)
  • Figure 41: United States Ophthalmic Disease Therapeutics Market Share, By Indication, By Value, 2023 (%)
  • Figure 42: United States Ophthalmic Disease Therapeutics Market Share, By Therapies, By Value, 2023 (%)
  • Figure 43: United States Ophthalmic Disease Therapeutics Market Share, By Distribution Channel, By Value, 2023 (%)
  • Figure 44: Canada Ophthalmic Disease Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 45: Canada Ophthalmic Disease Therapeutics Market Value, By Therapies, 2023 (USD Billion)
  • Figure 46: Canada Ophthalmic Disease Therapeutics Market Share, By Indication, By Value, 2023 (%)
  • Figure 47: Canada Ophthalmic Disease Therapeutics Market Share, By Therapies, By Value, 2023 (%)
  • Figure 48: Canada Ophthalmic Disease Therapeutics Market Share, By Distribution Channel, By Value, 2023 (%)
  • Figure 49: Rest of Americas Ophthalmic Disease Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 50: Rest of Americas Ophthalmic Disease Therapeutics Market Value, By Therapies, 2023 (USD Billion)
  • Figure 51: Rest of Americas Ophthalmic Disease Therapeutics Market Share, By Indication, By Value, 2023 (%)
  • Figure 52: Rest of Americas Ophthalmic Disease Therapeutics Market Share, By Therapies, By Value, 2023 (%)
  • Figure 53: Rest of Americas Ophthalmic Disease Therapeutics Market Share, By Distribution Channel, By Value, 2023 (%)
  • Figure 54: Europe Ophthalmic Disease Therapeutics Market Size, By Value, 2020H-2030F (USD Billion)
  • Figure 55: Europe Ophthalmic Disease Therapeutics Market Share, By Distribution Channel, 2023 (%)
  • Figure 56: Europe Ophthalmic Disease Therapeutics Market, By Age-related macular degeneration , By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 57: Europe Ophthalmic Disease Therapeutics Market, By Diabetic macular edema, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 58: Europe Ophthalmic Disease Therapeutics Market, By Other retinal disorders, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 59: Europe Ophthalmic Disease Therapeutics Market, By Anti VEGF, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 60: Europe Ophthalmic Disease Therapeutics Market, By Antibody - anti-IGF-1R, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 61: Europe Ophthalmic Disease Therapeutics Market, By Eye drops, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 62: Europe Ophthalmic Disease Therapeutics Market, By Other Therapies, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 63: Europe Ophthalmic Disease Therapeutics Market, By Hospital Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 64: Europe Ophthalmic Disease Therapeutics Market, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 65: Germany Ophthalmic Disease Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 66: Germany Ophthalmic Disease Therapeutics Market Value, By Therapies, 2023 (USD Billion)
  • Figure 67: Germany Ophthalmic Disease Therapeutics Market Share, By Indication, By Value, 2023 (%)
  • Figure 68: Germany Ophthalmic Disease Therapeutics Market Share, By Therapies, By Value, 2023 (%)
  • Figure 69: Germany Ophthalmic Disease Therapeutics Market Share, By Distribution Channel, By Value, 2023 (%)
  • Figure 70: United Kingdom Ophthalmic Disease Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 71: United Kingdom Ophthalmic Disease Therapeutics Market Value, By Therapies, 2023 (USD Billion)
  • Figure 72: United Kingdom Ophthalmic Disease Therapeutics Market Share, By Indication, By Value, 2023 (%)
  • Figure 73: United Kingdom Ophthalmic Disease Therapeutics Market Share, By Therapies, By Value, 2023 (%)
  • Figure 74: United Kingdom Ophthalmic Disease Therapeutics Market Share, By Distribution Channel, By Value, 2023 (%)
  • Figure 75: France Ophthalmic Disease Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 76: France Ophthalmic Disease Therapeutics Market Value, By Therapies, 2023 (USD Billion)
  • Figure 77: France Ophthalmic Disease Therapeutics Market Share, By Indication, By Value, 2023 (%)
  • Figure 78: France Ophthalmic Disease Therapeutics Market Share, By Therapies, By Value, 2023 (%)
  • Figure 79: France Ophthalmic Disease Therapeutics Market Share, By Distribution Channel, By Value, 2023 (%)
  • Figure 80: Italy Ophthalmic Disease Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 81: Italy Ophthalmic Disease Therapeutics Market Value, By Therapies, 2023 (USD Billion)
  • Figure 82: Italy Ophthalmic Disease Therapeutics Market Share, By Indication, By Value, 2023 (%)
  • Figure 83: Italy Ophthalmic Disease Therapeutics Market Share, By Therapies, By Value, 2023 (%)
  • Figure 84: Italy Ophthalmic Disease Therapeutics Market Share, By Distribution Channel, By Value, 2023 (%)
  • Figure 85: Spain Ophthalmic Disease Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 86: Spain Ophthalmic Disease Therapeutics Market Value, By Therapies, 2023 (USD Billion)
  • Figure 87: Spain Ophthalmic Disease Therapeutics Market Share, By Indication, By Value, 2023 (%)
  • Figure 88: Spain Ophthalmic Disease Therapeutics Market Share, By Therapies, By Value, 2023 (%)
  • Figure 89: Spain Ophthalmic Disease Therapeutics Market Share, By Distribution Channel, By Value, 2023 (%)
  • Figure 90: Rest of Europe Ophthalmic Disease Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 91: Rest of Europe Ophthalmic Disease Therapeutics Market Value, By Therapies, 2023 (USD Billion)
  • Figure 92: Rest of Europe Ophthalmic Disease Therapeutics Market Share, By Indication, By Value, 2023 (%)
  • Figure 93: Rest of Europe Ophthalmic Disease Therapeutics Market Share, By Therapies, By Value, 2023 (%)
  • Figure 94: Rest of Europe Ophthalmic Disease Therapeutics Market Share, By Distribution Channel, By Value, 2023 (%)
  • Figure 95: Asia Pacific Ophthalmic Disease Therapeutics Market Size, By Value, 2020H-2030F (USD Billion)
  • Figure 96: Asia Pacific Ophthalmic Disease Therapeutics Market Share, By Distribution Channel, 2023 (%)
  • Figure 97: Asia Pacific Ophthalmic Disease Therapeutics Market, By Age-related macular degeneration , By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 98: Asia Pacific Ophthalmic Disease Therapeutics Market, By Diabetic macular edema, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 99: Asia Pacific Ophthalmic Disease Therapeutics Market, By Other retinal disorders, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 100: Asia Pacific Ophthalmic Disease Therapeutics Market, By Anti VEGF, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 101: Asia Pacific Ophthalmic Disease Therapeutics Market, By Antibody - anti-IGF-1R, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 102: Asia Pacific Ophthalmic Disease Therapeutics Market, By Eye drops, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 103: Asia Pacific Ophthalmic Disease Therapeutics Market, By Other Therapies, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 104: Asia Pacific Ophthalmic Disease Therapeutics Market, By Hospital Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 105: Asia Pacific Ophthalmic Disease Therapeutics Market, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 106: China Ophthalmic Disease Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 107: China Ophthalmic Disease Therapeutics Market Value, By Therapies, 2023 (USD Billion)
  • Figure 108: China Ophthalmic Disease Therapeutics Market Share, By Indication, By Value, 2023 (%)
  • Figure 109: China Ophthalmic Disease Therapeutics Market Share, By Therapies, By Value, 2023 (%)
  • Figure 110: China Ophthalmic Disease Therapeutics Market Share, By Distribution Channel, By Value, 2023 (%)
  • Figure 111: Japan Ophthalmic Disease Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 112: Japan Ophthalmic Disease Therapeutics Market Value, By Therapies, 2023 (USD Billion)
  • Figure 113: Japan Ophthalmic Disease Therapeutics Market Share, By Indication, By Value, 2023 (%)
  • Figure 114: Japan Ophthalmic Disease Therapeutics Market Share, By Therapies, By Value, 2023 (%)
  • Figure 115: Japan Ophthalmic Disease Therapeutics Market Share, By Distribution Channel, By Value, 2023 (%)
  • Figure 116: India Ophthalmic Disease Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 117: India Ophthalmic Disease Therapeutics Market Value, By Therapies, 2023 (USD Billion)
  • Figure 118: India Ophthalmic Disease Therapeutics Market Share, By Indication, By Value, 2023 (%)
  • Figure 119: India Ophthalmic Disease Therapeutics Market Share, By Therapies, By Value, 2023 (%)
  • Figure 120: India Ophthalmic Disease Therapeutics Market Share, By Distribution Channel, By Value, 2023 (%)
  • Figure 121: Rest of Asia Pacific Ophthalmic Disease Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 122: Rest of Asia Pacific Ophthalmic Disease Therapeutics Market Value, By Therapies, 2023 (USD Billion)
  • Figure 123: Rest of Asia Pacific Ophthalmic Disease Therapeutics Market Share, By Indication, By Value, 2023 (%)
  • Figure 124: Rest of Asia Pacific Ophthalmic Disease Therapeutics Market Share, By Therapies, By Value, 2023 (%)
  • Figure 125: Rest of Asia Pacific Ophthalmic Disease Therapeutics Market Share, By Distribution Channel, By Value, 2023 (%)
  • Figure 126: Middle East and Africa Ophthalmic Disease Therapeutics Market Size, By Value, 2020H-2030F (USD Billion)
  • Figure 127: Middle East and Africa Ophthalmic Disease Therapeutics Market Share, By Distribution Channel, 2023 (%)
  • Figure 128: Middle East and Africa Ophthalmic Disease Therapeutics Market, By Age-related macular degeneration , By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 129: Middle East and Africa Ophthalmic Disease Therapeutics Market, By Diabetic macular edema, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 130: Middle East and Africa Ophthalmic Disease Therapeutics Market, By Other retinal disorders, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 131: Middle East and Africa Ophthalmic Disease Therapeutics Market, By Anti VEGF, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 132: Middle East and Africa Ophthalmic Disease Therapeutics Market, By Antibody - anti-IGF-1R, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 133: Middle East and Africa Ophthalmic Disease Therapeutics Market, By Eye drops, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 134: Middle East and Africa Ophthalmic Disease Therapeutics Market, By Other Therapies, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 135: Middle East and Africa Ophthalmic Disease Therapeutics Market, By Hospital Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 136: Middle East and Africa Ophthalmic Disease Therapeutics Market, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 137: Market Share of Prominent Companies of Ophthalmic Disease Therapeutics Market, 2023 (%)
  • Figure 138: Viatris Revenue, 2021-2023 (USD Million)
  • Figure 139: Viatris Revenue, By Geographical Segments, 2023 (%)
  • Figure 140: Viatris Revenue, By Business Segments, 2023 (%)
  • Figure 141: Sanofi Revenues, 2020-2022 (USD Million)
  • Figure 142: Sanofi Revenues, By Geographic Segments, 2022 (%)
  • Figure 143: Sanofi Revenue , By Business Segments, 2022 (%)
  • Figure 144: Novartis Revenues, 2021-2023 (USD Million)
  • Figure 145: Novartis Revenues, By Geographic Segments, 2023 (%)
  • Figure 146: Novartis Revenue , By Business Segments, 2023 (%)
  • Figure 147: Bayer AG Revenues 2021-2023(USD Million)
  • Figure 148: Bayer AG Revenues, By Geographic Segments, 2023 (%)
  • Figure 149: Bayer AG Revenues, By Business Segments, 2023 (%)
  • Figure 150: Teva Pharmaceuticals Revenues, 2020-2022 (USD Million)
  • Figure 151: Teva Pharmaceuticals Revenue , By Geographical Segments, 2022 (%)
  • Figure 152: Roche Revenues, 2021-2023 (USD Million)
  • Figure 153: Roche Revenue , By Sales Division, 2023 (%)
  • Figure 154: Roche Revenue , By Geographical Segment, 2023 (%)
  • Figure 155: AbbVie Inc. Revenues, 2021-2023 (USD Million)
  • Figure 156: AbbVie Inc. Revenue, Product Sales by Business Segment, 2023 (%)
  • Figure 157: AbbVie Inc. Revenue , By Geographical Segments, 2023 (%)
  • Figure 158: GSK PLC Revenue, 2020-2022 (USD Million)
  • Figure 159: GSK PLC Revenue , By Business Segments, 2023 (%)
  • Figure 160: GSK PLC Revenue, By Geography Segment, 2023 (%)

List of Tables

  • Table A1: Global Impact of Macro Economic Factors, By Region
  • Table A2: United States Ophthalmic Disease Therapeutics Market, By Indication, By Value, 2020-2023 (USD Billion)
  • Table A3: United States Ophthalmic Disease Therapeutics Market, By Indication, By Value, 2025-2030 (USD Billion)
  • Table A4: United States Ophthalmic Disease Therapeutics Market, By Therapies, By Value, 2020-2023 (USD Billion)
  • Table A5: United States Ophthalmic Disease Therapeutics Market, By Therapies, By Value, 2025-2030 (USD Billion)
  • Table A6: United States Ophthalmic Disease Therapeutics Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
  • Table A7: United States Ophthalmic Disease Therapeutics Market, By Distribution Channel, By Value, 2025-2030 (USD Billion)
  • Table A8: Canada Ophthalmic Disease Therapeutics Market, By Indication, By Value, 2020-2023 (USD Billion)
  • Table A9: Canada Ophthalmic Disease Therapeutics Market, By Indication, By Value, 2025-2030 (USD Billion)
  • Table A10: Canada Ophthalmic Disease Therapeutics Market, By Therapies, By Value, 2020-2023 (USD Billion)
  • Table A11: Canada Ophthalmic Disease Therapeutics Market, By Therapies, By Value, 2025-2030 (USD Billion)
  • Table A12: Canada Ophthalmic Disease Therapeutics Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
  • Table A13: Canada Ophthalmic Disease Therapeutics Market, By Distribution Channel, By Value, 2025-2030 (USD Billion)
  • Table A14: Rest of Americas Ophthalmic Disease Therapeutics Market, By Indication, By Value, 2020-2023 (USD Billion)
  • Table A15: Rest of Americas Ophthalmic Disease Therapeutics Market, By Indication, By Value, 2025-2030 (USD Billion)
  • Table A16: Rest of Americas Ophthalmic Disease Therapeutics Market, By Therapies, By Value, 2020-2023 (USD Billion)
  • Table A17: Rest of Americas Ophthalmic Disease Therapeutics Market, By Therapies, By Value, 2025-2030 (USD Billion)
  • Table A18: Rest of Americas Ophthalmic Disease Therapeutics Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
  • Table A19: Rest of Americas Ophthalmic Disease Therapeutics Market, By Distribution Channel, By Value, 2025-2030 (USD Billion)
  • Table A20: Germany Ophthalmic Disease Therapeutics Market, By Indication, By Value, 2020-2023 (USD Billion)
  • Table A21: Germany Ophthalmic Disease Therapeutics Market, By Indication, By Value, 2025-2030 (USD Billion)
  • Table A22: Germany Ophthalmic Disease Therapeutics Market, By Therapies, By Value, 2020-2023 (USD Billion)
  • Table A23: Germany Ophthalmic Disease Therapeutics Market, By Therapies, By Value, 2025-2030 (USD Billion)
  • Table A24: Germany Ophthalmic Disease Therapeutics Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
  • Table A25: Germany Ophthalmic Disease Therapeutics Market, By Distribution Channel, By Value, 2025-2030 (USD Billion)
  • Table A26: United Kingdom Ophthalmic Disease Therapeutics Market, By Indication, By Value, 2020-2023 (USD Billion)
  • Table A27: United Kingdom Ophthalmic Disease Therapeutics Market, By Indication, By Value, 2025-2030 (USD Billion)
  • Table A28: United Kingdom Ophthalmic Disease Therapeutics Market, By Therapies, By Value, 2020-2023 (USD Billion)
  • Table A29: United Kingdom Ophthalmic Disease Therapeutics Market, By Therapies, By Value, 2025-2030 (USD Billion)
  • Table A30: United Kingdom Ophthalmic Disease Therapeutics Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
  • Table A31: United Kingdom Ophthalmic Disease Therapeutics Market, By Distribution Channel, By Value, 2025-2030 (USD Billion)
  • Table A32: France Ophthalmic Disease Therapeutics Market, By Indication, By Value, 2020-2023 (USD Billion)
  • Table A33: France Ophthalmic Disease Therapeutics Market, By Indication, By Value, 2025-2030 (USD Billion)
  • Table A34: France Ophthalmic Disease Therapeutics Market, By Therapies, By Value, 2020-2023 (USD Billion)
  • Table A35: France Ophthalmic Disease Therapeutics Market, By Therapies, By Value, 2025-2030 (USD Billion)
  • Table A36: France Ophthalmic Disease Therapeutics Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
  • Table A37: France Ophthalmic Disease Therapeutics Market, By Distribution Channel, By Value, 2025-2030 (USD Billion)
  • Table A38: Italy Ophthalmic Disease Therapeutics Market, By Indication, By Value, 2020-2023 (USD Billion)
  • Table A39: Italy Ophthalmic Disease Therapeutics Market, By Indication, By Value, 2025-2030 (USD Billion)
  • Table A40: Italy Ophthalmic Disease Therapeutics Market, By Therapies, By Value, 2020-2023 (USD Billion)
  • Table A41: Italy Ophthalmic Disease Therapeutics Market, By Therapies, By Value, 2025-2030 (USD Billion)
  • Table A42: Italy Ophthalmic Disease Therapeutics Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
  • Table A43: Italy Ophthalmic Disease Therapeutics Market, By Distribution Channel, By Value, 2025-2030 (USD Billion)
  • Table A44: Spain Ophthalmic Disease Therapeutics Market, By Indication, By Value, 2020-2023 (USD Billion)
  • Table A45: Spain Ophthalmic Disease Therapeutics Market, By Indication, By Value, 2025-2030 (USD Billion)
  • Table A46: Spain Ophthalmic Disease Therapeutics Market, By Therapies, By Value, 2020-2023 (USD Billion)
  • Table A47: Spain Ophthalmic Disease Therapeutics Market, By Therapies, By Value, 2025-2030 (USD Billion)
  • Table A48: Spain Ophthalmic Disease Therapeutics Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
  • Table A49: Spain Ophthalmic Disease Therapeutics Market, By Distribution Channel, By Value, 2025-2030 (USD Billion)
  • Table A50: Rest of Europe Ophthalmic Disease Therapeutics Market, By Indication, By Value, 2020-2023 (USD Billion)
  • Table A51: Rest of Europe Ophthalmic Disease Therapeutics Market, By Indication, By Value, 2025-2030 (USD Billion)
  • Table A52: Rest of Europe Ophthalmic Disease Therapeutics Market, By Therapies, By Value, 2020-2023 (USD Billion)
  • Table A53: Rest of Europe Ophthalmic Disease Therapeutics Market, By Therapies, By Value, 2025-2030 (USD Billion)
  • Table A54: Rest of Europe Ophthalmic Disease Therapeutics Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
  • Table A55: Rest of Europe Ophthalmic Disease Therapeutics Market, By Distribution Channel, By Value, 2025-2030 (USD Billion)
  • Table A56: China Ophthalmic Disease Therapeutics Market, By Indication, By Value, 2020-2023 (USD Billion)
  • Table A57: China Ophthalmic Disease Therapeutics Market, By Indication, By Value, 2025-2030 (USD Billion)
  • Table A58: China Ophthalmic Disease Therapeutics Market, By Therapies, By Value, 2020-2023 (USD Billion)
  • Table A59: China Ophthalmic Disease Therapeutics Market, By Therapies, By Value, 2025-2030 (USD Billion)
  • Table A60: China Ophthalmic Disease Therapeutics Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
  • Table A61: China Ophthalmic Disease Therapeutics Market, By Distribution Channel, By Value, 2025-2030 (USD Billion)
  • Table A62: Japan Ophthalmic Disease Therapeutics Market, By Indication, By Value, 2020-2023 (USD Billion)
  • Table A63: Japan Ophthalmic Disease Therapeutics Market, By Indication, By Value, 2025-2030 (USD Billion)
  • Table A64: Japan Ophthalmic Disease Therapeutics Market, By Therapies, By Value, 2020-2023 (USD Billion)
  • Table A65: Japan Ophthalmic Disease Therapeutics Market, By Therapies, By Value, 2025-2030 (USD Billion)
  • Table A66: Japan Ophthalmic Disease Therapeutics Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
  • Table A67: Japan Ophthalmic Disease Therapeutics Market, By Distribution Channel, By Value, 2025-2030 (USD Billion)
  • Table A68: India Ophthalmic Disease Therapeutics Market, By Indication, By Value, 2020-2023 (USD Billion)
  • Table A69: India Ophthalmic Disease Therapeutics Market, By Indication, By Value, 2025-2030 (USD Billion)
  • Table A70: India Ophthalmic Disease Therapeutics Market, By Therapies, By Value, 2020-2023 (USD Billion)
  • Table A71: India Ophthalmic Disease Therapeutics Market, By Therapies, By Value, 2025-2030 (USD Billion)
  • Table A72: India Ophthalmic Disease Therapeutics Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
  • Table A73: India Ophthalmic Disease Therapeutics Market, By Distribution Channel, By Value, 2025-2030 (USD Billion)
  • Table A74: Rest of Asia Pacific Ophthalmic Disease Therapeutics Market, By Indication, By Value, 2020-2023 (USD Billion)
  • Table A75: Rest of Asia Pacific Ophthalmic Disease Therapeutics Market, By Indication, By Value, 2025-2030 (USD Billion)
  • Table A76: Rest of Asia Pacific Ophthalmic Disease Therapeutics Market, By Therapies, By Value, 2020-2023 (USD Billion)
  • Table A77: Rest of Asia Pacific Ophthalmic Disease Therapeutics Market, By Therapies, By Value, 2025-2030 (USD Billion)
  • Table A78: Rest of Asia Pacific Ophthalmic Disease Therapeutics Market, By Distribution Channel, By Value, 2020-2023 (USD Billion)
  • Table A79: Rest of Asia Pacific Ophthalmic Disease Therapeutics Market, By Distribution Channel, By Value, 2025-2030 (USD Billion)
  • Table A80: Viatris Key Company Financials, 2021-2023
  • Table A81: Sanofi Key Financials, 2020-2022
  • Table A82: Novartis Key Financials, 2021-2023
  • Table A83: Bayer AG Key Financials, 2021-2023
  • Table A84: Teva Pharmaceuticals Key Financials, 2021-2023
  • Table A85: Roche Key Financials, 2021-2023
  • Table A86: AbbVie Inc. Key Financials, 2021-2023
  • Table A87: GSK PLC Key Financials, 2020-2023
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!